Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases (eCARE-ID)

Yale University

Status: Withdrawn

Conditions: Alzheimer's Dementia; Antibiotics; Nursing Homes; Dementia

Treatments: Device: eCARE-ID; Other: Standard of Care

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04812769

2000029812

U54AG063546 (U.S. NIH Grant/Contract)

RFA-IMPACT-20-P02A (Other Grant/Funding Number)

Details and patient eligibility

About

Pilot study to evaluate the feasibility of a pilot embedded pragmatic cluster randomized controlled trial to reduce the duration of antibiotic therapy and number of antibiotic prescriptions in nursing home residents with AD/ADRD.

Full description

The overall objective of the proposed investigation is to assess the feasibility of a pilot embedded pragmatic cluster randomized controlled trial (ePCT) to reduce the duration of antibiotic therapy and number of antibiotic prescriptions among nursing home residents with AD/ADRD. With the support of three independently owned and operated nursing homes that are unaffiliated with an academic medical center, we have developed the multicomponent intervention, eCARE-ID (Electronic Consultation for AD/ADRD Residents Experiencing Infectious Diseases). eCARE-ID consists of three components: 1) Tele-ID video clinical consultation services for nursing home residents; 2) electronic consultation (e-consultation) services for healthcare personnel at participating nursing homes; and 3) Tele-ID video antibiotic stewardship services for healthcare personnel including pharmacists at participating nursing homes.

Sex: All

Ages: 65 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria - residence in a participating nursing home

Exclusion criteria:

• Not willing to consent to the study

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups, including a placebo group

Intervention

Experimental group

Description:

Two nursing homes will receive the eCARE-ID intervention

Treatment:

Device: eCARE-ID

Control

Placebo Comparator group

Description:

One control nursing home will receive infectious disease consultations and antibiotic stewardship services per routine practice.

Treatment:

Other: Standard of Care